Hospital
Sutter Bay Hospitals
Sutter Bay Hospitals was paid $11.12M by Medicaid between Jan 2018 and Nov 2024, across 105 billing codes. Its largest line is 99281, Emergency department visit for the evaluation and management, self-limited or minor — 26% of everything it billed.
33Billing provider infoSUTTER BAY HOSPITALS
NOVATO, CA 94945
NOVATO, CA 94945
33aNPI1104059153assigned 08/25/2009
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.12M
24GClaims178,403
24DCodes billed105
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#171 of 410
Median peer was paid$6.90M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official GATES, JOHN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,952 | $1.14M | |
| 2019 | 24,007 | $1.18M | |
| 2020 | 20,504 | $1.14M | |
| 2021 | 25,168 | $1.57M | |
| 2022 | 34,683 | $2.37M | |
| 2023 | 31,249 | $2.00M | |
| 2024incomplete | 21,840 | $1.72M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 26% | 20,711 | 17,313 | $2.91M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 21,485 | 18,705 | $1.66M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.2% | 1,249 | 1,174 | $695K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.1% | 4,479 | 3,994 | $571K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 4.0% | 1,838 | 1,800 | $443K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4.0% | 1,271 | 851 | $441K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.5% | 4,131 | 3,484 | $390K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.9% | 5,495 | 5,026 | $319K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.7% | 4,536 | 1,128 | $296K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.2% | 1,705 | 1,539 | $242K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.2% | 823 | 788 | $240K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.8% | 1,198 | 1,131 | $204K |
93 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 1,316 | $201K |
| 99201 | 1.7% | 702 | $184K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 3,184 | $163K |
| J3490 | Unclassified drugs | 1.4% | 12,381 | $158K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.4% | 1,097 | $156K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 2,468 | $139K |
| 97139 | 1.0% | 2,279 | $112K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,707 | $105K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 664 | $100K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,510 | $95K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,128 | $91K |
| 80053 | Comprehensive metabolic panel | <1% | 8,488 | $87K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 985 | $86K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,732 | $70K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,586 | $66K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,693 | $61K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,424 | $59K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 555 | $55K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,251 | $55K |
| 76830 | Ultrasound, transvaginal | <1% | 356 | $53K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,211 | $52K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,147 | $36K |
| 81001 | <1% | 6,982 | $31K | |
| 97799 | <1% | 667 | $31K | |
| 73562 | <1% | 458 | $29K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,127 | $27K |
| 97750 | <1% | 250 | $26K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 170 | $25K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,389 | $24K |
| 83690 | <1% | 3,913 | $22K | |
| 84484 | <1% | 2,686 | $22K | |
| 76642 | <1% | 147 | $21K | |
| 73610 | <1% | 298 | $20K | |
| 73630 | <1% | 265 | $18K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 676 | $17K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,546 | $15K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,218 | $14K |
| 81025 | <1% | 4,003 | $14K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,061 | $12K |
| 0450 | Emergency room services | <1% | 105 | $11K |
| Z7502 | <1% | 265 | $10K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 34 | $10K |
| 82077 | <1% | 484 | $9K | |
| 73030 | <1% | 124 | $9K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 128 | $8K |
| 87040 | <1% | 612 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 177 | $8K |
| 83605 | <1% | 724 | $6K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 43 | $6K |
| 73130 | <1% | 71 | $5K | |
| 85610 | <1% | 1,558 | $5K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 690 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 684 | $4K |
| 76536 | <1% | 43 | $4K | |
| 83735 | <1% | 689 | $3K | |
| 87430 | <1% | 310 | $3K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 26 | $3K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 380 | $3K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 484 | $3K |
| 87400 | <1% | 362 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 320 | $3K |
| 87077 | <1% | 307 | $3K | |
| 87186 | <1% | 292 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 87 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 79 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 79 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 379 | $2K |
| 87081 | <1% | 224 | $2K | |
| 83880 | <1% | 73 | $2K | |
| 73110 | <1% | 30 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 278 | $1K |
| 73080 | <1% | 15 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 100 | $1K |
| 82947 | <1% | 315 | $1K | |
| 73140 | <1% | 29 | $1K | |
| 85730 | <1% | 260 | $1K | |
| 72100 | <1% | 14 | $917.76 | |
| 85379 | <1% | 78 | $553.10 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 104 | $494.32 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 63 | $475.76 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 60 | $372.36 |
| 81003 | <1% | 173 | $269.88 | |
| 87420 | <1% | 66 | $147.42 | |
| S0028 | Injection, famotidine, 20 mg | <1% | 26 | $139.10 |
| 86900 | <1% | 47 | $99.76 | |
| 86901 | <1% | 47 | $97.53 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 14 | $97.28 |
| 87205 | <1% | 28 | $94.16 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 26 | $68.23 |
| 86140 | <1% | 15 | $64.82 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 16 | $61.50 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 112 | $2.16 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 13 | $1.95 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGATES, JOHN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Sutter Bay Hospitals | Castro Valley, CA | $52.65M |
| Sutter Bay Hospitals | Oakland, CA | $46.80M |
| Sutter Bay Hospitals | Berkeley, CA | $43.78M |
| Sutter Bay Hospitals | Lakeport, CA | $39.50M |
| Sutter Bay Hospitals | Santa Rosa, CA | $35.23M |
| Sutter Bay Hospitals | Antioch, CA | $29.48M |
| Sutter Bay Hospitals | San Francisco, CA | $19.99M |
| Sutter Bay Hospitals | Burlingame, CA | $17.15M |
| Sutter Bay Hospitals | San Francisco, CA | $14.94M |
| Sutter Bay Hospitals | San Francisco, CA | $6.79M |
| Sutter Bay Hospitals | Lakeport, CA | $3.99M |
| Sutter East Bay Hospitals | Antioch, CA | $3.45M |
| Sutter Bay Hospitals | Burlingame, CA | $1.98M |
| Sutter Bay Hospitals | Lakeport, CA | $1.72M |
| Sutter East Bay Hospitals | Oakland, CA | $1.10M |
| Sutter Bay Hospitals | San Francisco, CA | $1.08M |
| Sutter East Bay Hospitals | Berkeley, CA | $946K |
| Sutter West Bay Hospitals | San Francisco, CA | $186K |
| Magnetic Imaging Affiliates, LLC | Oakland, CA | $112K |
| Sutter Bay Hospitals | Berkeley, CA | $45K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.